DB
DXCM icon

Dmitry Balyasny’s DexCom DXCM Stock Holding History

Dmitry Balyasny’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,600
Closed -$504K – 3036
2025
Q4 		$504K Sell
7,600
-18,000
-70% -$1.16M ﹤0.01% 2521
2025
Q3 		$1.72M Sell
25,600
-26,400
-51% -$2.09M ﹤0.01% 1879
2025
Q2 		$4.54M Sell
52,000
-2,300
-4% -$180K 0.01% 1335
2025
Q1 		$3.71M Buy
54,300
+32,800
+153% +$2.68M 0.01% 1397
2024
Q4 		$1.67M Sell
21,500
-500
-2% -$37K ﹤0.01% 1738
2024
Q3 		$1.47M Buy
+22,000
New +$1.81M ﹤0.01% 1804
2023
Q4 		– Sell
-130,000
Closed -$12.1M – 2573
2023
Q3 		$12.1M Buy
+130,000
New +$14.7M 0.02% 777
2017
Q4 		– Sell
-80,000
Closed -$979K – 2114
2017
Q3 		$979K Buy
+80,000
New +$1.41M ﹤0.01% 1168

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dmitry Balyasny's DXCM Position: Q2 2026 in Review

Dmitry Balyasny sold out of DexCom (DXCM) in Q2 2026, closing a stake of 566,312 shares — an estimated $35.6M sold.

Dmitry Balyasny first reported a position in DXCM in Q3 2015 and held it in 29 quarters. The position peaked at $113M in Q4 2022. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Dmitry Balyasny reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 566,312 DexCom shares in Q2 2026, an estimated $35.6M.
  • Dmitry Balyasny first reported a position in DexCom in Q3 2015 and held it in 29 quarters.
  • Dmitry Balyasny's DexCom position peaked at $113M in Q4 2022.
  • 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.